vs
Side-by-side financial comparison of NATIONAL FUEL GAS CO (NFG) and Insulet Corporation (PODD). Click either name above to swap in a different company.
Insulet Corporation is the larger business by last-quarter revenue ($783.7M vs $425.9M, roughly 1.8× NATIONAL FUEL GAS CO). NATIONAL FUEL GAS CO runs the higher net margin — 35.7% vs 13.0%, a 22.7% gap on every dollar of revenue. On growth, Insulet Corporation posted the faster year-over-year revenue change (31.2% vs 1.7%). Over the past eight quarters, Insulet Corporation's revenue compounded faster (33.2% CAGR vs 12.1%).
National Fuel Gas Company is a diversified energy company with $6.2 billion in assets distributed among the following five operating segments: Exploration and Production, Pipeline and Storage, Gathering, Utility, and Energy Marketing. National Fuel Gas was incorporated in 1902 and is based in Williamsville, New York.
An insulin pump is a medical device used for the administration of insulin in the treatment of diabetes mellitus, also known as continuous subcutaneous insulin therapy . The device configuration may vary depending on design. A traditional pump includes:the pump a disposable reservoir for insulin a disposable infusion set, including a cannula for subcutaneous insertion and a tubing system to connect the insulin reservoir to the cannula.
NFG vs PODD — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $425.9M | $783.7M |
| Net Profit | $152.0M | $101.6M |
| Gross Margin | — | 72.6% |
| Operating Margin | 81.5% | 18.7% |
| Net Margin | 35.7% | 13.0% |
| Revenue YoY | 1.7% | 31.2% |
| Net Profit YoY | — | 0.9% |
| EPS (diluted) | $1.59 | $1.42 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $425.9M | — | ||
| Q4 25 | $637.9M | $783.7M | ||
| Q3 25 | $443.1M | $706.3M | ||
| Q2 25 | $527.4M | $649.1M | ||
| Q1 25 | $734.8M | $569.0M | ||
| Q4 24 | $513.8M | $597.5M | ||
| Q3 24 | $310.0M | $543.9M | ||
| Q2 24 | $338.6M | $488.5M |
| Q1 26 | $152.0M | — | ||
| Q4 25 | $181.6M | $101.6M | ||
| Q3 25 | $107.3M | $87.6M | ||
| Q2 25 | $149.8M | $22.5M | ||
| Q1 25 | $216.4M | $35.4M | ||
| Q4 24 | $45.0M | $100.7M | ||
| Q3 24 | $-167.6M | $77.5M | ||
| Q2 24 | $-54.2M | $188.6M |
| Q1 26 | — | — | ||
| Q4 25 | 86.6% | 72.6% | ||
| Q3 25 | — | 72.2% | ||
| Q2 25 | 94.7% | 69.7% | ||
| Q1 25 | 81.6% | 71.9% | ||
| Q4 24 | 87.3% | 72.1% | ||
| Q3 24 | — | 69.3% | ||
| Q2 24 | 98.5% | 67.7% |
| Q1 26 | 81.5% | — | ||
| Q4 25 | 43.3% | 18.7% | ||
| Q3 25 | 40.6% | 16.7% | ||
| Q2 25 | 43.7% | 18.7% | ||
| Q1 25 | 43.2% | 15.6% | ||
| Q4 24 | 16.8% | 18.3% | ||
| Q3 24 | -63.4% | 16.2% | ||
| Q2 24 | -15.2% | 11.2% |
| Q1 26 | 35.7% | — | ||
| Q4 25 | 28.5% | 13.0% | ||
| Q3 25 | 24.2% | 12.4% | ||
| Q2 25 | 28.4% | 3.5% | ||
| Q1 25 | 29.4% | 6.2% | ||
| Q4 24 | 8.8% | 16.9% | ||
| Q3 24 | -54.1% | 14.2% | ||
| Q2 24 | -16.0% | 38.6% |
| Q1 26 | $1.59 | — | ||
| Q4 25 | $1.98 | $1.42 | ||
| Q3 25 | $1.18 | $1.24 | ||
| Q2 25 | $1.64 | $0.32 | ||
| Q1 25 | $2.37 | $0.50 | ||
| Q4 24 | $0.49 | $1.38 | ||
| Q3 24 | $-1.81 | $1.08 | ||
| Q2 24 | $-0.59 | $2.59 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | — |
| Total DebtLower is stronger | $300.0M | $930.8M |
| Stockholders' EquityBook value | — | $1.5B |
| Total Assets | $9.1B | $3.2B |
| Debt / EquityLower = less leverage | — | 0.61× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $271.4M | — | ||
| Q3 25 | $43.2M | — | ||
| Q2 25 | $39.3M | — | ||
| Q1 25 | $40.0M | — | ||
| Q4 24 | $48.7M | — | ||
| Q3 24 | $38.2M | — | ||
| Q2 24 | $81.4M | — |
| Q1 26 | $300.0M | — | ||
| Q4 25 | $2.7B | $930.8M | ||
| Q3 25 | $2.7B | $934.9M | ||
| Q2 25 | $2.7B | $939.0M | ||
| Q1 25 | $2.7B | $1.6B | ||
| Q4 24 | $2.7B | $1.3B | ||
| Q3 24 | $2.7B | $1.4B | ||
| Q2 24 | $2.7B | $1.4B |
| Q1 26 | — | — | ||
| Q4 25 | $3.6B | $1.5B | ||
| Q3 25 | $3.1B | $1.4B | ||
| Q2 25 | $3.0B | $1.5B | ||
| Q1 25 | $2.8B | $1.3B | ||
| Q4 24 | $-76.2M | $1.2B | ||
| Q3 24 | $-15.5M | $1.1B | ||
| Q2 24 | $5.0M | $998.4M |
| Q1 26 | $9.1B | — | ||
| Q4 25 | $9.2B | $3.2B | ||
| Q3 25 | $8.7B | $3.0B | ||
| Q2 25 | $8.4B | $3.5B | ||
| Q1 25 | $8.5B | $3.5B | ||
| Q4 24 | $8.3B | $3.1B | ||
| Q3 24 | $8.3B | $3.0B | ||
| Q2 24 | $8.5B | $2.9B |
| Q1 26 | — | — | ||
| Q4 25 | 0.75× | 0.61× | ||
| Q3 25 | 0.87× | 0.68× | ||
| Q2 25 | 0.90× | 0.64× | ||
| Q1 25 | 0.99× | 1.21× | ||
| Q4 24 | — | 1.07× | ||
| Q3 24 | — | 1.21× | ||
| Q2 24 | 532.10× | 1.36× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $657.3M | $183.3M |
| Free Cash FlowOCF − Capex | — | $48.2M |
| FCF MarginFCF / Revenue | — | 6.2% |
| Capex IntensityCapex / Revenue | 117.0% | 17.2% |
| Cash ConversionOCF / Net Profit | 4.32× | 1.80× |
| TTM Free Cash FlowTrailing 4 quarters | — | $377.7M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $657.3M | — | ||
| Q4 25 | $274.9M | $183.3M | ||
| Q3 25 | $237.8M | $125.7M | ||
| Q2 25 | $388.4M | $196.5M | ||
| Q1 25 | $253.8M | $63.8M | ||
| Q4 24 | $220.1M | $147.7M | ||
| Q3 24 | $197.9M | $98.5M | ||
| Q2 24 | $281.8M | $96.5M |
| Q1 26 | — | — | ||
| Q4 25 | $-2.7M | $48.2M | ||
| Q3 25 | $-47.8M | $100.1M | ||
| Q2 25 | $195.3M | $177.9M | ||
| Q1 25 | $59.9M | $51.5M | ||
| Q4 24 | $-20.3M | $94.1M | ||
| Q3 24 | $-49.1M | $71.8M | ||
| Q2 24 | $79.5M | $74.0M |
| Q1 26 | — | — | ||
| Q4 25 | -0.4% | 6.2% | ||
| Q3 25 | -10.8% | 14.2% | ||
| Q2 25 | 37.0% | 27.4% | ||
| Q1 25 | 8.2% | 9.1% | ||
| Q4 24 | -4.0% | 15.7% | ||
| Q3 24 | -15.8% | 13.2% | ||
| Q2 24 | 23.5% | 15.1% |
| Q1 26 | 117.0% | — | ||
| Q4 25 | 43.5% | 17.2% | ||
| Q3 25 | 64.4% | 3.6% | ||
| Q2 25 | 36.6% | 2.9% | ||
| Q1 25 | 26.4% | 2.2% | ||
| Q4 24 | 46.8% | 9.0% | ||
| Q3 24 | 79.7% | 4.9% | ||
| Q2 24 | 59.7% | 4.6% |
| Q1 26 | 4.32× | — | ||
| Q4 25 | 1.51× | 1.80× | ||
| Q3 25 | 2.21× | 1.43× | ||
| Q2 25 | 2.59× | 8.73× | ||
| Q1 25 | 1.17× | 1.80× | ||
| Q4 24 | 4.89× | 1.47× | ||
| Q3 24 | — | 1.27× | ||
| Q2 24 | — | 0.51× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NFG
| Revenues from External Customers | $425.8M | 100% |
| Intersegment Revenues | $126.0K | 0% |
PODD
| U.S.Omnipod | $567.8M | 72% |
| International Omnipod | $214.0M | 27% |
| Drug Delivery | $1.9M | 0% |
